摘要
目的:对比钆贝葡胺(Gd-BOPTA)增强核磁共振(MRI)与CT多期增强扫描(MDCT)对肝硬化伴小肝癌诊断的临床价值。方法:对2018年1月至2019年1月在我院诊治的肝硬化伴小肝癌患者96例进行Gd-BOPTA增强MRI与MDCT,比较两种检查方法在病灶检出、病灶显示、肿瘤各期强化特点及包膜边缘强化特点。结果:96例患者共检出142个病灶,MRI对结节体积大小测量的准确性、病灶检出率、医生诊断信心评分均要高于CT,差异有统计学意义(P<0.05)。MRI对典型病灶检出率、对小肝癌包膜边缘强化均优于CT(P<0.05)。结论:与CT相比,MRI对肝硬化伴小肝癌的诊断更敏感、准确,尤其结合LAVA序列及Gd-BOPTA增强扫描可以大大提高小肝癌的检出率。
Objective:To compare the clinical value of Gd-BOPTA enhanced MRI and multi-phase enhanced CT scan(MDCT)in the diagnosis of liver cirrhosis with small liver cancer.Methods:From January 2018 to January 2019,a total of 96 patients with liver cirrhosis and small liver cancer in our hospital were selected for Gd-BOPTA enhanced MRI and CT multi-phase enhanced scanning,and the two inspection methods were compared.The detection of the lesions,the display of the lesions,the enhancement characteristics of each stage of SHCC,and the enhancement characteristics of the envelope edge.Results:There were 142 lesions in 96 patients.The accuracy of MRI's measurement of nodule size,lesion detection rate,and doctor's diagnostic confidence score were all higher than those of CT,and the difference was statistically significant(P<0.05).MRI was superior to CT in the detection rate of typical lesions and the enhancement of SHCC envelope edge(P<0.05).Conclusion:Compared with CT,MRI is more sensitive to liver cirrhosis with small liver cancer.In particular,combining LAVA sequence and Gd-BOPTA enhanced scanning can greatly improve the detection rate of small liver cancer.
作者
王德志
胡海洋
郭长华
宋磊
WANG De-zhi;HU Hai-yang;GUO Chang hua(Benxi Steel General Hospital of China Resources liaojian group,Radiology Department(Liaoning,Benxi,117000),China)
出处
《中西医结合肝病杂志》
CAS
2021年第5期449-451,共3页
Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
基金
辽宁省科学技术计划项目(No.2019-ZD-0916)。
关键词
肝硬化
小肝癌
钆贝葡胺
CT多期增强扫描
诊断效能
liver cirrhosis
small liver cancer
gadolinium meglumine
CT multi-phase enhanced scanning
diagnostic power